Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 9.0

(0.0%)

Market Cap (In HKD)

972 Million

Revenue (In HKD)

4.4 Billion

Net Income (In HKD)

51.34 Million

Avg. Volume

24.12 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
6.81-14.82
PE
-
EPS
-
Beta Value
-0.469
ISIN
CNE1000023D6
CUSIP
Y1601Y109
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Distribution
CEO
Mr. Chuanglong Yao
Employee Count
-
Website
https://www.chmyy.com
Ipo Date
2015-12-14
Details
Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.